Form 4: Compass Pathways Director Malievskaia Reports Stock Sales Under 10b5-1 Plan

Ekaterina Malievskaia, a director at Compass Pathways, reported the sale of ordinary shares under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 28, 2024, Ekaterina Malievskaia, a director at COMPASS Pathways plc, reported the sale of 25,750 ordinary shares at a weighted average price of $8.6515.
• These sales were executed automatically under a Rule 10b5-1 trading plan adopted on August 23, 2023.
• Following the transaction, Malievskaia directly owns 4,033,880 ordinary shares.
• An additional 25,750 shares were sold from securities held by her spouse, George Jay Goldsmith, resulting in his holding of 4,036,154 ordinary shares.
• Malievskaia and Goldsmith disclaim beneficial ownership of each other's shares.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing regarding stock sales by an insider under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This filing is a routine disclosure of stock sales by a company insider, which is a common occurrence in publicly traded companies. The use of a 10b5-1 trading plan suggests the sales were pre-planned and not based on any inside information.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading.
• The use of Rule 10b5-1 trading plans is a common method for corporate insiders to sell shares without raising concerns about insider trading, similar to practices at companies like Pfizer or Moderna where executives may have pre-arranged sales plans.

Stakeholder Impact

• The stock sales by a director and their spouse could have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates